Putting novel ablation technologies to the test-Reference-Cited by-同舟云学术

Putting novel ablation technologies to the test

Published:2023-02-23 Issue:4 Volume:25 Page:1312-1314
ISSN:1099-5129
Container-title:EP Europace
language:en
Short-container-title:

Author:

Althoff Till F¹²^ORCID

Affiliation:

1. Arrhythmia Section, Cardiovascular Institute (ICCV), Clínic—University Hospital Barcelona , Carrer Villarroel 170, Barcelona 08036, Catalonia , Spain

2. Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) , Barcelona, Catalonia , Spain

Publisher

Oxford University Press (OUP)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Link

https://academic.oup.com/europace/article-pdf/25/4/1312/49919619/euad046.pdf

Reference15 articles.

1. Novel concepts in atrial fibrillation ablation-breaking the trade-off between efficacy and safety;Althoff;J Arrhythm,2021

2. Impact of complete versus incomplete circumferential lines around the pulmonary veins during catheter ablation of paroxysmal atrial fibrillation: results from the Gap-Atrial Fibrillation-German Atrial Fibrillation Competence Network 1 trial;Kuck;Circ Arrhythm Electrophysiol,2016

3. Ablation lesion assessment with MRI;Mont;Arrhythm Electrophysiol Rev,2022

4. Late gadolinium enhancement-MRI determines definite lesion formation most accurately at three months post ablation compared to later time points;Althoff;Pacing Clin Electrophysiol,2021

5. Accuracy of left atrial fibrosis detection with cardiac magnetic resonance: correlation of late gadolinium enhancement with endocardial voltage and conduction velocity;Caixal;Europace,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Atrial Ablation Lesion Evaluation by Cardiac Magnetic Resonance;JACC: Clinical Electrophysiology;2023-12

2. Does the spatial distribution of atrial arrhythmogenic substrate matter? Insights from the DECAAF II trial;Europace;2023-08-02